Clinical Trials Browser

Interventional × Triple Negative Breast Neoplasms × ostarine × Clear all

NCT02368691 2020-11-18

Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)

Phase 2 Terminated

32 enrolled 12 charts

Triple Negative Breast Neoplasms